HMOs Should Emphasize Cost Management R&D When Lobbying - Wall Street
Executive Summary
Managed care should emulate the pharmaceutical industry's approach to lobbying by emphasizing the value of its research and development initiatives, Deutsche Banc Alex. Brown Managing Director Gary Frazier told the American Association of Health Plans Medicaid and Medicare conference Sept. 13 in Washington, D.C.